193 results on '"Yao, J.C."'
Search Results
2. Novel composite nanomaterials with superior thermal and pressure stability for potential LED applications
3. Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study
4. Strong red emission and catalytic properties of ZnO by adding Eu2O3 shell
5. Approximate Cayley transform methods for inverse eigenvalue problems and convergence analysis
6. A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial
7. 46MO FRESCO-2: A global / multiregional phase III clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with metastatic colorectal cancer
8. LBA25 FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer
9. A unified hybrid iterative method for hierarchical minimization problems
10. 526P Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: A FRESCO-2 subgroup analysis by age
11. Ni–Al–O diffusion barrier layer for high-κ metal-oxide-semiconductor capacitor
12. Analyse finale de la survie globale dans l’étude de phase 3 NETTER-1 du Lu-DOTATATE chez les patients atteints de tumeurs neuroendocrines de l’intestin moyen
13. Pseudo-Lipschitz property of linear semi-infinite vector optimization problems
14. Implicit iterative algorithms for asymptotically nonexpansive mappings in the intermediate sense and Lipschitz-continuous monotone mappings
15. Degree theory for generalized variational inequalities and applications
16. On relaxed viscosity iterative methods for variational inequalities in Banach spaces
17. Existence of vector mixed variational inequalities in Banach spaces
18. Cauchy–Dirichlet problem for second-order hyperbolic equations in cylinders with non-smooth base
19. 1102P The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses
20. Approximate proximal algorithms for generalized variational inequalities with paramonotonicity and pseudomonotonicity
21. Approximate proximal algorithms for generalized variational inequalities with pseudomonotone multifunctions
22. Solving variational inequalities involving nonexpansive type mappings
23. Well-posedness of generalized mixed variational inequalities, inclusion problems and fixed-point problems
24. Application of a coincidence index to some classes of impulsive control systems
25. An implicit iterative scheme for monotone variational inequalities and fixed point problems
26. Asymptotic solution for nonlinear buckling of orthotropic shells on elastic foundation
27. Strong convergence theorems for finitely many nonexpansive mappings and applications
28. Equilibrium Problems with Applications to Eigenvalue Problems
29. Existence of Solutions to Implicit Vector Variational Inequalities
30. Gap Functions and Existence of Solutions to Set-Valued Vector Variational Inequalities
31. Characterizations of Solutions for Vector Equilibrium Problems
32. Integrating targeted treatments with tumor biology and molecular imaging in the current and future management of neuroendocrine gastrointestinal tumors
33. 403MO Atezolizumab in combination with bevacizumab for patients with unresectable/metastatic anal cancer
34. Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
35. Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors
36. A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial
37. Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
38. Therapy of localized gastric cancer: preoperative and postoperative approaches
39. Impact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study
40. Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
41. Existence of Solutions for Generalized Vector Equilibrium Problems
42. The north American neuroendocrine tumor society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors.
43. PS04.05 ElevatION NET 201:Ph II Study of PDR001 in Metastatic, Well Differentiated NET of Pancreatic/GI/Thoracic Origin or Poorly Differentiated GEP NEC
44. A Phase II study of sorafenib and yttrium-90 glass microspheres for advanced hepatocellular carcinoma, BCLC stage C
45. Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
46. Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors
47. LBA47 - Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
48. 177 Lu-Dotatate améliore significativement la survie sans progression des patients atteints de tumeurs neuroendocrines métastatiques progressives de l’intestin moyen : résultats de l’essai de phase III NETTER-1
49. A new incremental constraint projection method for solving monotone variational inequalities
50. 1316P - Impact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.